Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS

Table of Contents

September 01, 2001; Volume 28,Issue 9
  • You have access
    The spectrum of the antiphospholipid syndrome: a matter of perspective.
    C A Clark, K A Spitzer and C A Laskin
    The Journal of Rheumatology September 1 2001, 28 (9) 1939-1941;
  • You have access
    Infections in rheumatoid arthritis--a new phenomenon?
    M F Doran and S E Gabriel
    The Journal of Rheumatology September 1 2001, 28 (9) 1942-1943;
  • You have access
    Manpower in Canadian academic rheumatology units: current status and future trends. Canadian Council of Academic Rheumatologists.
    J G Hanly and Canadian Council of Academic Rheumatologists
    The Journal of Rheumatology September 1 2001, 28 (9) 1944-1951;
  • You have access
    Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
    A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
    The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;
  • You have access
    Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
    The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;
  • You have access
    Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
    W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
    The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;
  • You have access
    Carpal collapse in rheumatoid arthritis--prevalence and clinical significance: a preliminary study.
    L Daza, F Arroyo, J Dozal and J Morales
    The Journal of Rheumatology September 1 2001, 28 (9) 1975-1978;
  • You have access
    Power Doppler ultrasound assessment of rheumatoid hand synovitis.
    M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
    The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;
  • You have access
    Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
    The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;
  • You have access
    In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
    A B Mongey and E Hess
    The Journal of Rheumatology September 1 2001, 28 (9) 1992-1998;
  • You have access
    Disease status predicts fatigue in systemic lupus erythematosus.
    W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
    The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;
  • You have access
    Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
    The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;
  • You have access
    Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
    S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
    The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;
  • You have access
    Risk factors associated with thrombosis in patients with antiphospholipid antibodies.
    K E Hansen, D F Kong, K D Moore and T L Ortel
    The Journal of Rheumatology September 1 2001, 28 (9) 2018-2024;
  • You have access
    A study of 75 pregnancies in patients with antiphospholipid syndrome.
    D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
    The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;
  • You have access
    Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
    P J Nietert, M D Silverstein and R M Silver
    The Journal of Rheumatology September 1 2001, 28 (9) 2031-2037;
  • You have access
    Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage.
    H A Kim, D I Suh and Y W Song
    The Journal of Rheumatology September 1 2001, 28 (9) 2038-2045;
  • You have access
    Visual hallucinations in giant cell arteritis: association with visual loss.
    G Nesher, R Nesher, Y Rozenman and M Sonnenblick
    The Journal of Rheumatology September 1 2001, 28 (9) 2046-2048;
  • You have access
    Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
    S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
    The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;
  • You have access
    Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
    R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
    The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;
  • You have access
    Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation.
    G Trudel, N Desaulniers, H K Uhthoff and O Laneuville
    The Journal of Rheumatology September 1 2001, 28 (9) 2066-2074;
  • You have access
    Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
    M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
    The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;
  • You have access
    Health status in fibromyalgia--a followup study.
    A M Mengshoel and M Haugen
    The Journal of Rheumatology September 1 2001, 28 (9) 2085-2089;
  • You have access
    Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
    D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
    The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;
  • You have access
    Physician resistance to the late whiplash syndrome.
    S N Virani, R Ferrari and A S Russell
    The Journal of Rheumatology September 1 2001, 28 (9) 2096-2099;
  • You have access
    Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
    A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
    The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;
  • You have access
    Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
    The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;
  • You have access
    Resorption of the temporomandibular condylar bone according to subtypes of juvenile chronic arthritis.
    T K Pedersen, J J Jensen, B Melsen and T Herlin
    The Journal of Rheumatology September 1 2001, 28 (9) 2109-2115;
  • You have access
    Incidence of pediatric rheumatic diseases in a regional population in Austria.
    C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
    The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;
  • You have access
    Etanercept in the treatment of macrophage activation syndrome.
    S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
    The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;
  • You have access
    Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy.
    K Nistala and K J Murray
    The Journal of Rheumatology September 1 2001, 28 (9) 2125-2128;
  • You have access
    Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine.
    K W Morgan and J P Callen
    The Journal of Rheumatology September 1 2001, 28 (9) 2129-2132;
  • You have access
    Nephrotoxicity of selective COX-2 inhibitors.
    A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
    The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;
  • You have access
    Osteoarthropathy associated with Weber-Christian disease.
    T Yamamoto, K Nagira, T Akisue and M Kurosaka
    The Journal of Rheumatology September 1 2001, 28 (9) 2136-2138;
  • You have access
    Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
    J Wenzel and T Bieber
    The Journal of Rheumatology September 1 2001, 28 (9) 2139;
  • You have access
    Occupational factors in systemic sclerosis.
    B Noël
    The Journal of Rheumatology September 1 2001, 28 (9) 2139-2140;
  • You have access
    Dural sinus thrombosis in childhood systemic lupus erythematosus.
    B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
    The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;
  • You have access
    Endocarditis in adult onset Still's disease: a 12 month followup.
    C García-Porrúa, C González-Juanatey and M A González-Gay
    The Journal of Rheumatology September 1 2001, 28 (9) 2141-2142;
  • You have access
    Idiopathic lateral sinus thrombosis mimicking giant cell arteritis.
    C García-Porrúa, J Vega Andión and M A González-Gay
    The Journal of Rheumatology September 1 2001, 28 (9) 2142-2143;
  • You have access
    The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's Disease.
    C Pata, K Konica and A Yazar
    The Journal of Rheumatology September 1 2001, 28 (9) 2144;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 28, Issue 9
1 Sep 2001
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • The Rheumatologist’s Role in COVID-19
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • COVID-19 and Rheumatic Diseases: It Is Time to Better Understand This Association
  • The Effect of HLA-B27 on Susceptibility and Severity of COVID-19
  • Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire